BILLERICA, Mass. – Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis announced today that the Department of Systems Biology at the MD Anderson Cancer Center has acquired another 2470 microarray printer from Aushon BioSystems.

The new 2470 Arrayer will be utilized in the Cancer Center Support Grant (CCSG) Functional Proteomics Reverse Phase Protein Array (RPPA) Facility, a core facility that serves all researchers at MD Anderson Cancer Center, as well as other academic institutions and industries. Extremely high demand for RPPA data and the proven performance of the existing 2470 Arrayer helped drive the acquisition of the additional microarray printer. Combined with the current 2470 on-site, the ability of the Functional Proteomics RPPA Facility to meet the higher throughput demands for biomarker research and diagnostic testing on cancer patients’ protein pathways and drug reaction will be significantly expanded.

“For each project, we are able to print over 1000 serially diluted samples and 1000 controls on hundreds of slides with our current 2470 microarray printer,” said Gordon Mills, Chairman of the Department of Systems Biology, Chief of the Section of Molecular Therapeutics, and Professor of Medicine and Immunology at the University of Texas MD Anderson Cancer Center. “This has enabled us to analyze about 200 different proteins and their modifications per project. The CCSG Functional Proteomics RPPA Facility is among the most utilized at MD Anderson, and with the acquisition of our second Aushon 2470, the RPPA core, as well as other RPPA users affiliated with the Department of Systems Biology, will be able to greatly increase the output of RPPA data.”

The Aushon 2470 Arrayer has been installed in leading institutions throughout North America, Europe and Asia to provide rapid, accurate, high-density microarray printing for both genomic and proteomic applications. It is able to print virtually any sample – including cell lysates and blood – onto substrates with unique shapes and chemistries, as well as a wide range of substrates such as nitrocellulose and silicon chips. Engineered with walk-away automation, the unique solid pin architecture and proprietary pin design make the 2470 the most flexible and reliable microarray printing platform available.

About Aushon BioSystems:

Aushon BioSystems provides a comprehensive suite of multiplex immunoassay products and services for protein biomarker discovery, development and analysis to leading pharmaceutical, biotechnology, academic and diagnostic clients worldwide. Our unique combination of advanced microarray printing technology, robust biomarker content and an innovative multiplex immunoassay technology platform delivers exceptional performance, quality and reliability that accelerate pre-clinical and clinical biomarker research. Our customers trust us to provide the most reliable protein biomarker data available, which lowers costs and improves research productivity. For more information, visit www.aushon.com.